160
Participants
Start Date
July 15, 2022
Primary Completion Date
October 31, 2026
Study Completion Date
November 30, 2027
Topical Ripasudil
To determine the effect of rho-kinase inhibitors on endothelial cell loss
Topical Placebo
topical Placebo
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
Wills Eye Hospital, Philadelphia
RECRUITING
University of Miami, Palm Beach Gardens
RECRUITING
Stanford University, Palo Alto
RECRUITING
University of California Davis, Sacramento
RECRUITING
Oregon Health & Science University, Portland
RECRUITING
Dartmouth-Hitchcock Medical Center, Lebanon
Oregon Health and Science University
OTHER
University of California, San Francisco
OTHER
University of California, Davis
OTHER
Case Western Reserve University
OTHER
Dartmouth-Hitchcock Medical Center
OTHER
University of Pennsylvania
OTHER
University of Miami
OTHER
Wills Eye Hospital
UNKNOWN
Stanford University
OTHER